How effective is Simvastatin for Diabetes Mellitus (Diabetes)? (a real world drug study)
Summary:
Overall ratings: 3.4/5 Long term ratings: 3.6/5
This is a phase IV clinical study of how effective Simvastatin (simvastatin) is for Diabetes mellitus and for what kind of people. The study is created by eHealthMe from 21 Simvastatin users and is updated continuously.
What is Simvastatin?
Simvastatin has active ingredients of simvastatin. It is often used in high blood cholesterol. eHealthMe is studying from 256,970 Simvastatin users. Check the latest studies of Simvastatin.
What is Diabetes mellitus?
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin) is found to be associated with 2,946 drugs and 2,904 conditions by eHealthMe. Check the latest studies of Diabetes mellitus.
21 people are studied for taking Simvastatin in Diabetes mellitus
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Simvastatin effectiveness for Diabetes mellitus (number of people):
Overall:
- not at all: 0
- somewhat: 4
- moderate: 8
- high: 6
- very high: 3
Long Term:
- not at all: 0
- somewhat: 2
- moderate: 7
- high: 6
- very high: 3
Gender of people who take Simvastatin for Diabetes mellitus *:
- female: 42.86 %
- male: 57.14 %
Age of people who take Simvastatin for Diabetes mellitus *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 4.76 %
- 30-39: 9.52 %
- 40-49: 9.52 %
- 50-59: 19.05 %
- 60+: 57.14 %
Who find Simvastatin more effective for Diabetes Mellitus?
Gender of people who take Simvastatin for Diabetes mellitus *:
- female: 55.56 %
- male: 44.44 %
Age of people who take Simvastatin for Diabetes mellitus *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 11.11 %
- 50-59: 11.11 %
- 60+: 77.78 %
* Approximation only. Some reports may have incomplete information.
Do you take Simvastatin?
- You can start a phase IV clinical trial to monitor Simvastatin safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies:
- Dobrosavljevi? Vukojevi? D, Stojkovi? Filipovi? J, Sjerobabin M, Vukovi? J, Vesi? S, "Lisinopril-induced pemphigus foliaceus in a patient with diabetes mellitus and Kaposi-Juliusberg varicelliform eruption", Serbian Journal of Dermatology and Venerology, 2012 Dec .
- Dobrosavljevi? Vukojevi? D, Stojkovi? Filipovi? J, Sjerobabin M, Vukovi? J, Vesi? S, "Lisinopril-induced pemphigus foliaceus in a patient with diabetes mellitus and Kaposi-Juliusberg varicelliform eruption", Serbian Journal of Dermatology and Venerology, 2012 Dec .
Related studies
Alternative drugs to, pros and cons of:
- Simvastatin (256,970 reports)
Treatments, associated drugs and conditions:
- Diabetes mellitus (466,617 reports)
How the study uses the data?
The study is based on simvastatin (the active ingredients of Simvastatin) and Simvastatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Norvasc cause Hypertrophic Cardiomyopathy? - 14 seconds ago
- Klonopin and Aspirin drug interactions for women aged 60+ - 19 seconds ago
- Miralax and Spastic Colon for Men aged 60+ - 38 seconds ago
- Miralax and Nervous Indigestion for Men aged 60+ - 38 seconds ago
- Miralax and Mucous Colitis for Men aged 60+ - 38 seconds ago
- Miralax and Laxative Colitis for Men aged 60+ - 38 seconds ago
- Miralax and Irritable Colon for Men aged 60+ - 39 seconds ago
- Miralax and Intestinal Neurosis for Men aged 60+ - 39 seconds ago
- Miralax and Ibs for Men aged 60+ - 39 seconds ago
- Miralax and Functional Colitis for Men aged 60+ - 40 seconds ago